Share Capital Founded -
Founders Cui Xinxin
Portfolio analytics
News & Media
Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 49
Average round size
The average size of a deal this fund participated in
Portfolio companies 39
Lead investments 9
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 4
Stages of investment
Early Stage Venture
Areas of investment
Consumer Goods
Health Care

The leading representative office of defined VC is situated in the Shenzhen. The fund was located in Asia if to be more exact in China.

Among the most popular portfolio startups of the fund, we may highlight MiningLamp, Easyhin Technology, Genetron Health. The fund has exact preference in a number of founders of portfolio startups. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. Among the most successful fund investment fields, there are Robotics, Food and Beverage. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China.

The top activity for fund was in 2018. The common things for fund are deals in the range of 10 - 50 millions dollars. Considering the real fund results, this VC is 34 percentage points more often commits exit comparing to other organizations. The fund is constantly included in 2-6 deals per year.

The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Share Capital, startups are often financed by ZhenFund, Zhejiang Xianju Pharmaceutical, Yingke Capital. The meaningful sponsors for the fund in investment in the same round are Red Star Macalline, Hotata, Zhongyuan Union Cell & Gene Eng. In the next rounds fund is usually obtained by Tencent Holdings, Zhongjin Kangrui Medical Industrial Fund, Vivo Capital.

Read more
Notable deals
CompanyIndustryRoundRound SizeDateInvestorsLocation
CoWin Biosciences
Life Science
37M02 Sep 2020 United States, Boston
Cwbio IT Group
Life Science
37M29 Aug 2020 China, Changping District
Denovo Biopharma
Health Care
Early Stage Venture
45M31 Oct 2019 United States, San Diego
Early Stage Venture
15M02 Nov 2018
Early Stage Venture
1M16 Aug 2018
Late Stage Venture
22M26 Jun 2018
17 May 2018
Food and Beverage
Media and Entertainment
Performing Arts
Early Stage Venture
08 Apr 2018 China, Futian District
10M21 Mar 2018
  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Share Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Crunchbase icon

Content report

The following text will be sent to our editors: